Neurobiology of Aging
Volume 30, Issue 10 , Pages 1601-1607 , October 2009

Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease

  • Xiu-Hua Bi

      Affiliations

    • National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, PR China
    • ,
  • Hua-Lu Zhao

      Affiliations

    • National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, PR China
    • ,
  • Zhen-Xin Zhang

      Affiliations

    • Department of Neurology, Peking Union Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, PR China
    • ,
  • Jun-Wu Zhang

      Affiliations

    • National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 10 65296423; fax: +86 10 65240529.

Received 8 August 2007 ,Revised 23 November 2007 ,Accepted 14 December 2007.

References 

  1. Brunellia T, Bagnolib S, Giustia B, Nacmiasb B, Pepea G, Sorbib S, et al. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neurosci. Lett. 2001;315:103–105
  2. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol. Genet. Metab. 2000;70:310–315
  3. Chapman J, Wang NS, Treves TA, Korczyn AD, Bornstein NM. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke. 1998;29:1401–1404
  4. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998;55:1449–1455
  5. Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am. J. Clin. Nutr. 2006;83:708–713
  6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995;10:111–113
  7. Gellekink H, Blom HJ, den Heijer M. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk. Clin. Chem. Lab. Med. 2007;45:471–476
  8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J. Lipid Res. 1990;31:545–548
  9. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenete trahydrofolate reductase. Am. J. Hum. Genet. 1988;43:414–421
  10. Kluijtmans LJ, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101:2483–2488
  11. Linnebank M, Linnebank A, Jeub M, Klockgether T, Wullner U, Kolsch H, et al. Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am. J. Med. Genet. 2004;131:101–102
  12. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J. Methelenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410–2416
  13. Martinez ME, Thompson P, Jacobs ET, Giovannucci E, Jiang R, Klimecki W, et al. Dietary factors and biomarkers involved in the methyenetetrahydrofolate reductase genotype-colrectal adenoma pathway. Gastroenterology. 2006;131:1706–1716
  14. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in northern Ireland. Stroke. 2002;33:2351–2356
  15. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Method Enzymol. 1997;281:43–53
  16. Morin I, Devlin AM, Leclerc D, Sabbaghian N, Halsted CH, Finnell R, et al. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol. Genet. Metab. 2003;79:197–200
  17. Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology. 1997;112:783–791
  18. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, NaÈgga K, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 2001;9:437–444
  19. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004;80:114–122
  20. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 2005;82:636–643
  21. Seripa D, Forno GD, Matera MG, Gravina C, Margaglione M, Palermo MT, et al. Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol. Aging. 2003;24:933–939
  22. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’agostino PB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Eng. J. Med. 2002;346:476–483
  23. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am. J. Clin. Nutr. 2000;71:993–998
  24. Veselá K, Pavlíková M, Janošíková B, Anděl M, Zvárová J, Hyánek J, et al. Genetic determinants of folate status in central bohemia. Physiol. Res. 2005;54:295–303
  25. Wakutani Y, Kowa H, Kusumi M, Nakaso K, Yasui K, Isoe-Wada K, et al. A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer's disease. Neurobiol. Aging. 2004;25:291–294
  26. Wang B, Jin F, Kan R, Ji S, Zhang CF, Lu ZP, et al. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. J. Mol. Neurosci. 2005;27:23–27
  27. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J. Med. Genet. 2003;40:619–625
  28. Yang-Feng TL, Ma YY, Liang R, Prasad PD, Leibach FH, Ganapathy V. Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridisation. Biochem. Biophys. Res. Commun. 1995;210:874–879
  29. Zhloba AA, Blashko EL. Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J. Chromatogr. B. 2004;800:275–280

PII: S0197-4580(07)00487-3

doi: 10.1016/j.neurobiolaging.2007.12.010

Neurobiology of Aging
Volume 30, Issue 10 , Pages 1601-1607 , October 2009

Article Tools